Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Pediatr Dermatol ; 35(1): e84-e85, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29231256

ABSTRACT

There are few reports of chemotherapy-induced eccrine squamous syringometaplasia in children. We report the first case of an infant developing this condition after treatment with busulfan, fludarabine, and antithymocyte globulin in preparation for bone marrow transplantation. Twenty-eight days after transplantation, the infant developed faintly erythematous papules and plaques on the bilateral axillae, inguinal folds, and sites of adhesives. Punch biopsy revealed eccrine glands with dyskeratotic cells and focal squamous metaplasia consistent with chemotherapy-induced eccrine squamous syringometaplasia.


Subject(s)
Drug Eruptions/diagnosis , Eccrine Glands/pathology , Immunosuppressive Agents/adverse effects , Sweat Gland Diseases/pathology , Bone Marrow Transplantation/adverse effects , Humans , Infant , Male , Metaplasia , Skin/pathology , Sweat Gland Diseases/chemically induced
2.
Dermatol Online J ; 24(9)2018 Sep 15.
Article in English | MEDLINE | ID: mdl-30677834

ABSTRACT

Trichoblastic carcinoma is a rare carcinoma often arising in a pre-existing trichoblastoma. It may resemble basal cell carcinoma, posing a diagnostic challenge. Trichoblastic carcinoma is divided into low-grade and high-grade tumors. Low-grade tumors resemble basal cell carcinomas and are therefore synonymous in some classifications. High-grade tumors, which commonly present on the scalp in older individuals or in patients with Brooke-Spiegler syndrome, have been associated with a higher potential for distant metastasis and death. We present a case in which a 73-year-old female had a long-standing scalp nodule for over 30 years that rapidly increased in size. The patient's lesion was initially diagnosed as basal cell carcinoma on shave biopsy, but upon excision, revealed features concerning for trichoblastic carcinoma such as brisk mitotic activity and comedo-like necrosis. Sudden change in an atypical scalp lesion that has been present for many years should increase suspicion for an atypical trichogenic tumor, such as trichoblastic carcinoma.


Subject(s)
Carcinoma, Basal Cell/pathology , Skin Neoplasms/pathology , Aged , Biopsy , Carcinoma, Basal Cell/surgery , Dermoscopy , Female , Humans , Mohs Surgery , Skin Neoplasms/surgery
3.
J Immunol ; 194(11): 5150-60, 2015 Jun 01.
Article in English | MEDLINE | ID: mdl-25911752

ABSTRACT

Human peripheral monocytes have been categorized into three subsets based on differential expression levels of CD14 and CD16. However, the factors that influence the distribution of monocyte subsets and the roles that each subset plays in autoimmunity are not well studied. In this study, we show that circulating monocytes from patients with autoimmune uveitis exhibit a skewed phenotype toward intermediate CD14(++)CD16(+) cells, and that this is associated with glucocorticoid therapy. We further demonstrate that CD14(++)CD16(+) monocytes from patients and healthy control donors share a similar cell-surface marker and gene expression profile. Comparison of the effects of intermediate CD14(++)CD16(+) monocytes with classical CD14(++)CD16(-) and nonclassical CD14(+)CD16(++) monocytes revealed that the intermediate CD14(++)CD16(+) subset had an attenuated capacity to promote both naive CD4(+) T cell proliferation and polarization into a Th1 phenotype, and memory CD4(+) T cell proliferation and IL-17 expression. Furthermore, CD14(++)CD16(+) cells inhibit CD4(+) T cell proliferation induced by other monocyte subsets and enhance CD4(+) T regulatory cell IL-10 expression. These data demonstrate the impact of glucocorticoids on monocyte phenotype in the context of autoimmune disease and the differential effects of monocyte subsets on effector T cell responses.


Subject(s)
Glucocorticoids/pharmacology , Leukocytes, Mononuclear/immunology , Lipopolysaccharide Receptors/metabolism , Receptors, IgG/metabolism , T-Lymphocytes, Regulatory/immunology , Autoimmune Diseases/immunology , Autoimmunity , Cell Differentiation/immunology , Cell Proliferation , Cells, Cultured , Dexamethasone/pharmacology , GPI-Linked Proteins/metabolism , Humans , Interferon-gamma/biosynthesis , Interleukin-10/biosynthesis , Interleukin-17/biosynthesis , Lymphocyte Activation/immunology , Th1 Cells/cytology , Th1 Cells/immunology , Uveitis/immunology
4.
Retina ; 34(2): 366-72, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23958842

ABSTRACT

PURPOSE: To evaluate fundus autofluorescence (FAF) patterns in patients with primary intraocular (vitreoretinal) lymphoma. METHODS: Records of all patients with primary intraocular lymphoma who underwent FAF imaging at the National Eye Institute were reviewed. Fundus autofluorescence patterns were evaluated with respect to clinical disease status and the findings on fluorescein angiography and spectral-domain optical coherence tomography. RESULTS: There were 18 eyes (10 patients) with primary intraocular lymphoma that underwent FAF imaging. Abnormal autofluorescence in the form of granular hyperautofluorescence and hypoautofluorescence was seen in 11 eyes (61%), and blockage by mass lesion was seen in 2 eyes (11%). All eyes with granular pattern on FAF had active primary intraocular lymphoma at the time of imaging, but there were 5 eyes with unremarkable FAF, which were found to have active lymphoma. The most common pattern on fluorescein angiography was hypofluorescent round spots with a "leopard spot" appearance (43%). These hypofluorescent spots on fluorescein angiography correlated with hyperautofluorescent spots on FAF in 5 eyes (36%) (inversion of FAF). Nodular hyperreflective spots at the level of retinal pigment epithelium on optical coherence tomography were noted in 43% of eyes. The hyperautofluorescent spots on FAF correlated with nodular hyperreflective spots on optical coherence tomography in 6 eyes (43%). CONCLUSION: Granularity on FAF was associated with active lymphoma in majority of the cases. An inversion of FAF (hyperautofluorescent spots on FAF corresponding to hypofluorescent spots on fluorescein angiography) was observed in less than half of the eyes.


Subject(s)
Fluorescein Angiography , Intraocular Lymphoma/diagnosis , Retinal Neoplasms/diagnosis , Vitreous Body/pathology , Fundus Oculi , Humans , Lymphoma, Large B-Cell, Diffuse/diagnosis , Optical Imaging , Tomography, Optical Coherence
5.
Plant J ; 72(6): 882-93, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22709376

ABSTRACT

Diverse pathogens secrete effector proteins into plant cells to manipulate host cellular processes. Oomycete pathogens contain large complements of predicted effector genes defined by an RXLR host cell entry motif. The genome of Hyaloperonospora arabidopsidis (Hpa, downy mildew of Arabidopsis) contains at least 134 candidate RXLR effector genes. Only a small subset of these genes is conserved in related oomycetes from the Phytophthora genus. Here, we describe a comparative functional characterization of the Hpa RXLR effector gene HaRxL96 and a homologous gene, PsAvh163, from the Glycine max (soybean) pathogen Phytophthora sojae. HaRxL96 and PsAvh163 are induced during the early stages of infection and carry a functional RXLR motif that is sufficient for protein uptake into plant cells. Both effectors can suppress immune responses in soybean. HaRxL96 suppresses immunity in Nicotiana benthamiana, whereas PsAvh163 induces an HR-like cell death response in Nicotiana that is dependent on RAR1 and Hsp90.1. Transgenic Arabidopsis plants expressing HaRxL96 or PsAvh163 exhibit elevated susceptibility to virulent and avirulent Hpa, as well as decreased callose deposition in response to non-pathogenic Pseudomonas syringae. Both effectors interfere with defense marker gene induction, but do not affect salicylic acid biosynthesis. Together, these experiments demonstrate that evolutionarily conserved effectors from different oomycete species can suppress immunity in plant species that are divergent from the source pathogen's host.


Subject(s)
Glycine max/immunology , Nicotiana/immunology , Oomycetes/physiology , Plant Diseases/immunology , Plant Immunity , Proteins/metabolism , Amino Acid Motifs , Amino Acid Sequence , Biological Evolution , Gene Expression , Gene Expression Regulation, Plant , Glucans/metabolism , Host-Pathogen Interactions , Molecular Sequence Data , Phytophthora/physiology , Plant Diseases/microbiology , Plant Leaves/genetics , Plant Leaves/immunology , Plant Leaves/microbiology , Plants, Genetically Modified , Protein Structure, Tertiary , Pseudomonas syringae/physiology , Sequence Alignment , Glycine max/genetics , Glycine max/microbiology , Nicotiana/genetics , Nicotiana/microbiology , Transgenes
7.
Ocul Immunol Inflamm ; 22(4): 270-6, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24377379

ABSTRACT

PURPOSE: To evaluate the type and number of diagnostic interventions needed to confirm the presence of vitreoretinal lymphoma. METHOD: Chart review of interventions performed for diagnosis of vitreoretinal lymphoma. RESULTS: Of the 27 cases, diagnosis was made by pars plana vitrectomy in 13 (48.1%), vitreous tap in 2 (7.4%), anterior chamber tap in 1 (3.7%), chorioretinal biopsy in 2 (7.4%), brain biopsy in 5 (18.5%), and cerebrospinal fluid cytology via lumbar puncture in 4 (14.8%). Ten (37%) had definitive results on the first procedure, and 17 (63%) had at least one false negative. Vitrectomy was the most common procedure performed. Patients required a mean of 2.1 procedures. Average time from onset of symptoms to confirmed histopathologic diagnosis was 13.9 months. CONCLUSION: Vitreoretinal lymphoma is difficult to recognize and requires a high degree of clinical suspicion. It often takes more than one invasive procedure to make the diagnosis.


Subject(s)
Lymphoma/diagnosis , Retinal Neoplasms/diagnosis , Vitreous Body/pathology , Adult , Aged , Biopsy , Diagnosis, Differential , Female , Flow Cytometry , Follow-Up Studies , Humans , Lymphoma/surgery , Male , Middle Aged , Retinal Neoplasms/surgery , Retrospective Studies , Vitrectomy/methods , Vitreous Body/surgery
8.
Br J Ophthalmol ; 95(12): 1738-44, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21873312

ABSTRACT

BACKGROUND: The complement activation molecule C5a has been found in the eye and is implicated in the pathogenesis of ocular inflammatory diseases. In this study, the authors sought to investigate C5a's effects on human retinal pigment epithelial (RPE) cells and peripheral blood mononuclear cells (PBMCs), and on the interaction between RPE cells and PBMCs. METHODS: Arising retinal pigment epithelia cell line-19 and PBMCs isolated from healthy donors were used in this study. Western blot, real-time PCR and cell surface receptor staining were used to detect C5a receptor expression. Real-time PCR was used to detect cytokine mRNA expression. A thiazolyl blue tetrazolium bromide assay was used to detect cell viability. Cells were stained with Annexin V and 7-aminoactinomycin D for an apoptosis assay. Cell proliferation was measured using a tritiated thymidine incorporation assay. RESULTS: C5a receptors were present on RPE cells, and receptor expression was increased by pro-inflammatory cytokines. C5a suppressed RPE cells' production of transforming growth factor ß2, an important immunosuppressive agent in the eye. In addition, the viability of RPE cells was decreased in the presence of C5a, and this effect was not due to apoptosis. C5a increased proliferation of PBMCs and upregulated their production of pro-inflammatory cytokines. Finally, C5a decreased RPE cells' ability to suppress immune cell proliferation. CONCLUSION: The results provide a direct link between complement activation and intraocular inflammation. This line of information may help to understand the mechanism of the pathogenesis of intraocular inflammatory diseases. Moreover, the authors show that a close, reciprocal interaction between the innate immune system and the adaptive immune system may be involved in the development of such diseases.


Subject(s)
Complement C5a/immunology , Cytokines/metabolism , Eye/metabolism , Eye/pathology , Immunologic Factors/immunology , Leukocytes, Mononuclear/metabolism , Pigment Epithelium of Eye/metabolism , Receptor, Anaphylatoxin C5a/immunology , Apoptosis , Blotting, Western , Cell Proliferation , Cell Survival , Cells, Cultured , Coloring Agents , Cytokines/immunology , Electrophoresis, Polyacrylamide Gel , Eye/immunology , Eye Diseases/metabolism , Eye Diseases/pathology , Gene Expression , Humans , Inflammation/metabolism , Inflammation/pathology , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/pathology , Pigment Epithelium of Eye/immunology , Pigment Epithelium of Eye/pathology , RNA, Messenger/metabolism , Real-Time Polymerase Chain Reaction , Tetrazolium Salts , Thiazoles , Transforming Growth Factor beta2/metabolism , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL